for position only investors rule
recent press releases
Jan 19, 2012
Adeona Announces Initiation of Phase II Clinical Trial of Trimesta™ for Cognitive Dysfunction in Multiple Sclerosis
Dec 21, 2011
Adeona Announces Proposed Name Change to Synthetic Biologics, Inc., and Appointment of John Monahan, Ph.D., as Senior Vice President of Research & Development
Nov 30, 2011
Positive Clinical Study Results Reported by Adeona's Oral Zinc for ALS Collaborator
Nov 21, 2011
Adeona Pharmaceuticals and Intrexon Announce Worldwide Exclusive Collaboration for Synthetic DNA-based Therapy for Pulmonary Arterial Hypertension
Nov 14, 2011
Adeona Reports Third Quarter 2011 Financial Results
Featured Events
Adeona 3rd Quarter 2011 Investor Conference Call
Monday, November 14, 2011
2:00pm EST
stock quote
Print Email